OMPI – Recherche dans les collections de brevets nationales et internationales

1.2004/02457ANTIMICROBIALLY-TREATED FABRICS

ZA - 28.06.2006

CIB A61K N° de demande 2004/02457 Déposant KIMBERLY-CLARK WORLDWIDE, INC. Inventeur James W CLARK

A method for forming an antimicrobially-treated fabric is provided. The method includes forming a solution from a liquid and an antimicrobial agent, such as 3-(trimethoxysilyl)propyloctadecyldimethyl ammonium chloride. In one embodiment, a cellulosic fibrous material is combined with a solution while in the pulper to form a liquid suspension such that the antimicrobial agent becomes substantive to the cellulosic fibrous material. A web is formed from the antimicrobially-treated cellulosic fibrous material such that substantially all of the cellulosic fibrous material present within the web is derived from the antimicrobially-treated cellulosic fibrous material. In one embodiment, the web of antimicrobially-treated fibrous material is also hydraulically entangled with a nonwoven substrate. In some embodiments, when dried, the antimicrobial agent forms a covalent bond with the cellulosic fibrous material.

2.2004/02592SYSTEM FOR THE DETECTION OF UREASE AND METHOD FOR USING SAME

ZA - 28.06.2006

CIB G01N N° de demande 2004/02592 Déposant KIMBERLY-CLARK WORLDWIDE, INC. Inventeur Barry J MARSHALL

A diagnostic system (20) for diagnostic testing having a carrier (22) including at least one well (26, 8), and a specimen-handling tool (24) disposed about at least a portion of the well.

3.2004/02651APPARATUS AND METHOD FOR RETROFITTING GAMING MACHINES TO ISSUE AND REDEEM TICKETS

ZA - 30.11.2005

CIB A63F N° de demande 2004/02651 Déposant ARISTOCRAT TECHNOLOGIES, INC Inventeur F VAN BALTZ

validator and ticket 316 in order to redeem tickets.

4.2004/02699METHOD AND DEVICE FOR THE CONTINUOUS PRODUCTION OF A ROLLED METAL STRIP FROM A MOLTEN METAL

ZA - 29.06.2005

CIB B21B N° de demande 2004/02699 Déposant VOEST-ALPINE INDUSTRIEANLAGENBAU GMBH & CO Inventeur Gerald HOHENBICHLER

The invention relates to a method and to a device for producing a rolled metal strip from a molten metal by producing a cast metal strip in a strip casting device (5) and then rolling the undivided metal strip in a roll stand (18) to the final thickness of the strip. For controlling the course of the strip, strip guiding devices (19) are provided, especially upstream of the roll stand. In order to guarantee, with little components required, a stable insertion of the metal strip into the roll stand at the input side of the roll stand or at the site of rolling in accordance with the strip dimensions, the strip guidance interferes or is carried out at a distance of 1.0 to 10.0 times the strip width, preferably at a distance of 1.5 to 5.0 times the strip width, upstream of the roll stand.

5.2004/02832SOLAR HEAT COLLECTOR

ZA - 31.05.2006

CIB F24J N° de demande 2004/02832 Déposant IVANOVIC NICHOLAS Inventeur Nicholas IVANOVIC

( 12) having a transparent window ( 16) for receiving solar radiation ⁽ 18) into the container ( 12) and ΙΛ rctleciive support surface (20₎, opposite to the transparent window ( 16). for supporting collector tubing ( 14), and an array of collec tor tubing, the tubes (22₎ of the tubing ( 14) being generally anranged in parallel and spaced apart from another on the surface such tBnat, in use, when solar radiation enters the container with an iracidence an le of the com onent perpendicular to the tubin bein be-tween 0" and 70" the

6.2004/03227SECURE AUTHENTICATION AND PAYMENT SYSTEM

ZA - 27.07.2005

CIB G06F N° de demande 2004/03227 Déposant MOHSENZADEH HOSSEIN Inventeur Hossein MOHSENZADEH,

7.2004/03207THERAPEUTIC QUINOLONE COMPOUNDS WITH 5-HT ANTAGONISTIC PROPERTIES

ZA - 30.03.2005

CIB A61K N° de demande 2004/03207 Déposant ASTRAZENECA AB Inventeur Daniel SOHN

the formula (Γ) (R² is typically a tertiary nitrogen atom, being either alkyl-substituted or member of q heterocyclic ring; R⁷ is typically a monocyclic or bicyclic aromatic ring or a heterocyclic ring) wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT_1B and 5HT_1D antagonists.

8.2004/03307METHOD FOR SELECTING GENETICALLY TRANSFORMED CELLS

ZA - 30.03.2005

CIB A01H N° de demande 2004/03307 Déposant EXPRESSIVE RESEARCH B.V Inventeur Josephus Christianus Maria SMEEKENS

with transformed and non-transformed cells into contact with trehalose and/or derivative thereof; and c) selecting the transformed cells from the population on the basis of the capacity of the transformed cells to metabolize the trehalose and/or derivative.

9.2004/03326SYNERGISTIC HERBICIDAL COMPOSITIONS COMPRISING HERBICIDES FROM THE GROUP OF THE BENZOYLPYRAZOLES

ZA - 30.03.2005

CIB A01N N° de demande 2004/03326 Déposant BAYER CROPSCIENCE GMBH Inventeur LOTHAR WILLMS

10.2004/03352TETRAHYDROCARBOZOLE DERIVATES AS LIGANDS FOR G-PROTEIN COUPLED RECEPTORS (GPCR)

ZA - 24.11.2004

CIB A61K N° de demande 2004/03352 Déposant ZENTARIS GMBH Inventeur Marcus KOPPITZ

(GPCR), especially as antagonists of gonado ropin-releasing hormone (GnRH). The invention also relates to a pharmaceutical composition containing said novel tetrahydrocarbozole derivatives, and to a method for producing the same. Furthermore, the invention relates to the administration of tetrahydrocarbozole derivatives for the treatment of pathological conditions mediated by GPCR, especially for the inhibition of GnRH, to mammals, especially humans, requiring such treatment, and to the use of tetrahydrocarbozole derivatives for producing a pharmaceutical agent for treating pathological conditions mediated by GPCR, especially for the inhibition of GnRH.
(57) Zusammenfassung: Die vorliegende Erfindung stellt neue Tetrahydrocarbazol-Derivate bereit, die als Liganden fur G-Protein gekoppelteRezeptoren (GPCR), insbesondere als Antagonisten des Gonadotropin-freisetzenden Hormons (GnRH) wirken. Femer wird eine pharmazeutische Zusammensetzung, enthaltend diese neuen Tetrahydrocarbazol-Derivate, sowie ein Verfahren zur Herstel-lung der neuen Tetrahydrocarbazol-Derivate bereitgestellt. DarUber hinaus betrifft die vorliegende Erfindung die Verabreichung von Tetrahydrocarbazol-Derivaten zur Behandlung von durch GPCR vermittelten Krankheitszustanden, insbesondere zur Inhibierung des GnRH, an Saugetiere, insbesondere Menschen, die eine solche Verabreichung benOtigen, sowie die Verwendung von Tetrahydrocarbazol-Derivaten zurHerstellung eines pharmazeutischen Mittels zur Behandlung von durch GPCR vermittelten Krankheitszustanden, insbesondere zur Inhibierung des GnRH.

1 / 15 193

Aller à l'entrée de recherche	`CTRL` + `SHIFT` +
Aller aux résultats (entrée sélectionnée)	`CTRL` + `SHIFT` +
Aller au détail (onglet sélectionné)	`CTRL` + `SHIFT` +
Aller à la page suivante	`CTRL` +
Aller à la page précédente	`CTRL` +

Aller à l'entrée / image suivante	/
Aller à l'entrée / image précédente	/
Faire défiler vers le haut	`Page Up`
Faire défiler vers le bas	`Page Down`
Faire défiler jusqu'au haut de la page	`CTRL` + `Home`
Faites défiler jusqu'au bas de la page	`CTRL` + `End`

Traitement en cours

Entrées en phase nationale

Fichier d'autorité

Paramétrages

Commentaires

Aller à Demande

Enregistrer la requête

Arbre de requête

Affiner les options

Requête complète

Raccourcis en vue côte à côte

Analyse

Aller à l'onglet suivant
Aller à l'onglet précédent